poster
Conflicts of Interest and the Role of Funders and Authors in Clinical Trials Included in Cochrane Reviews
keywords:
conflict of interest
funding/sponsorship
Objective In Cochrane reviews, trial authors’ conflicts of
interest are often not reported and trial funding information
is sometimes missing.1,2 This study assessed (1) the proportion
of Cochrane reviews reporting trial funding and authors’
conflicts of interest and (2) whether accessing the main trial
publication and searching other information sources could
identify additional information on funding, conflicts of
interest, and the role of funders and authors.
Design In a cross-sectional study, 1 index trial was randomly
included from the primary meta-analyses of 100 Cochrane
reviews (October to December 2020). Two authors
independently extracted trial characteristics, funding and
conflict of interest information, and the role of funders and
authors from the reviews and main trial publications,
including conflict of interest disclosure forms. Other sources
(eg, trial protocols and registry information) were also
searched to retrieve additional information, and the time this
took was noted. The proportion of Cochrane reviews and
main trial publications reporting trial funding and conflict of
interest information and role of funders and authors were
calculated, as was the proportion of trials in which additional
information was found by searching other sources.
Results The included trials were published from 1975 to
2020 (median: 2011), and 47 were drug trials. Sixty-eight
reviews reported trial funding, and 25 reported trial authors’
conflicts of interest. Accessing the main trial publication led
to identification of funding in 16 additional trials and conflict
of interest information in 38 additional trials. In trials in
which funders or trial authors had conflicts of interest, their
roles were sufficiently reported in 20 of 36 (56%) and 20 of
30 (67%) main trial publications, respectively. It took
approximately 9 minutes (range, 2-28 minutes) per trial
publication to extract information. When searching other
sources, additional information on funding was found in 2
trials and authors’ conflicts of interest in 13 trials, and it took
approximately 22 minutes (range, 4-97 minutes) per trial to
extract information. Trial registries and other publications by
trial authors were the information sources that most
frequently contained additional information.
Conclusions One-third of recent Cochrane reviews did not
report funding of a randomly selected included trial, and
three-quarters did not report trial authors’ conflicts of
interest despite the information often being reported in the
main trial publication. Review authors should systematically
access and read main trial publications and disclosure
statements and consider searching other information sources.
References
1. Turner K, Carboni-Jiménez, Benea C, et al. Reporting of
drug trial funding sources and author financial conflicts of
interest in Cochrane and non-Cochrane meta-analyses: a
cross-sectional study. BMJ Open. 2020;10:e035633.
doi:10.1136/bmjopen-2019-035633
2. Roseman M, Turner EH, Lexchin J, et al. Reporting of
conflicts of interest from drug trials in Cochrane reviews:
cross sectional study. BMJ. 2012;345:e5155. doi:10.1136/bmj.
e5155
Conflict of Interest Disclosures Isabelle Boutron, Lesley
Stewart, Asbjørn Hróbjartsson, and Andreas Lundh are members
of the TACIT Steering Group involved in developing a Tool for
Addressing Conflicts of Interest in Trials. Isabelle Boutron is a
member of the Peer Review Congress Advisory Board but was
not involved in the review or decision for this abstract. No other
disclosures were reported.
Additional Information Andreas Lundh is a co–
corresponding author.